NEW: 'Kairos' cLDEP Particle Sorter   More info...

News

  • Jun 2015
    The new A50-Micro+ is now in Production
    With no compromises, it is designed for small particle performance. By light scatter alone it resolves 80nm latex beads from noise and particle size differences as small as 10nm. Multiple high sensitivity light scatter and fluorescence detectors allow the study of particles far below the sensitivity limits of conventional flow cytometers. The Micro+ model is for research into extracellular vesicles (microparticles), virus and other nanoparticles.
  • May 2015
    New "A50-Micro +"

    New "A50-Micro +" dedicated to analysis of microvesicles and large virus.

    Apogee announces the launch date for this new version of the A50-Micro with uncompromised performance for the smallest particles measurable.

    Available with higher power lasers, higher sensitivity photomultiplier detectors and more aggressively tuned optics, the A50-Micro + will secure Apogee's lead in small particle flow cytometry.

  • Apr 2015
    ISEV 2015

    Apogee sponsors the annual meeting of the International Society for Extracellular Vesicles.

    ISEV 2015 will be held in Washington DC at the Bethesda North Marriott hotel, 23-25 April 2015.

  • Apr 2015
    ApogeeMix Special Offer

    For a limited period Apogee is offering its ApogeeMix bead mixture (Cat#1493, ApogeeMix, latex fluorescent 110 & 500nm plus silica 180, 240, 300, 590, 880 & 1300nm, 25ml) at the reduced price of GBP135 or US$200.

    The item may be ordered by emailing your purchase order to info@apogeeflow.com Quote code “ApoMix” to make sure you receive the special offer price.

  • Apr 2015
    Visit Apogee at CYTO 2015
    Visit Apogee at CYTO 2015 booth 520 where the new Micro+ model will be on display. The Micro+ offers uncompromised performance for microvesicle, virus and nanoparticle research.

    CYTO 2015
    XXX Congress of the International Society for Advancement of Cytometry
    June 26 - 30, 2015, Glasgow, Scotland
< | Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next | >
Get In Touch
Visit our Facebook page Follow us on Twitter Connect with us on LinkedIn